59 related articles for article (PubMed ID: 17910837)
1. [Are bone scintigraphy examinations requested in oncologic patients according to established indications?].
Cortés Romera M; Talavera Rubio MP; García Vicente AM; Ruiz Solís S; Poblete García VM; Rodríguez Alfonso B; Palomar Muñoz A; Soriano Castrejón A
Rev Esp Med Nucl; 2007; 26(5):286-93. PubMed ID: 17910837
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
[TBL] [Abstract][Full Text] [Related]
3. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.
Schirrmeister H; Buck A; Guhlmann A; Reske SN
Thyroid; 2001 Jul; 11(7):677-83. PubMed ID: 11484897
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
Lecouvet FE; Geukens D; Stainier A; Jamar F; Jamart J; d'Othée BJ; Therasse P; Vande Berg B; Tombal B
J Clin Oncol; 2007 Aug; 25(22):3281-7. PubMed ID: 17664475
[TBL] [Abstract][Full Text] [Related]
5. [Carcinoid tumor and bone metastases: diagnosis by somatostatin receptor scintigraphy].
Banzo J; Abós MD; Prats E; Razola P; García S; Alonso V; Velilla J; García F; Ubieto MA; Tardín L
Rev Esp Med Nucl; 2004; 23(6):394-402. PubMed ID: 15625056
[TBL] [Abstract][Full Text] [Related]
6. When to Perform Preoperative Bone Scintigraphy for Kidney Cancer Staging: Indications for Preoperative Bone Scintigraphy.
Larcher A; Muttin F; Fossati N; Dell'Oglio P; Di Trapani E; Stabile A; Ripa F; Trevisani F; Carenzi C; Picchio M; Briganti A; Salonia A; Mottrie A; Bertini R; Montorsi F; Capitanio U
Urology; 2017 Dec; 110():114-120. PubMed ID: 28890151
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.
Cook GJ; Venkitaraman R; Sohaib AS; Lewington VJ; Chua SC; Huddart RA; Parker CC; Dearnaley DD; Horwich A
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):7-13. PubMed ID: 20697891
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic imaging of bone metastases].
Scutellari PN; Addonisio G; Righi R; Giganti M
Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
[TBL] [Abstract][Full Text] [Related]
9. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
[TBL] [Abstract][Full Text] [Related]
11. Bone scan and liver ultrasound scan in the preoperative staging for primary breast cancer.
Kasem AR; Desai A; Daniell S; Sinha P
Breast J; 2006; 12(6):544-8. PubMed ID: 17238984
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
[TBL] [Abstract][Full Text] [Related]
13. Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study.
Bristow AR; Agrawal A; Evans AJ; Burrell HC; Cornford EJ; James JJ; Hamilton L; Robertson JF; Chan SY; Lawton PA; Cheung KL
Breast; 2008 Feb; 17(1):98-103. PubMed ID: 17890090
[TBL] [Abstract][Full Text] [Related]
14. [Metastatic bone disease. Strategies for imaging].
Scutellari PN; Antinolfi G; Galeotti R; Giganti M
Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
[TBL] [Abstract][Full Text] [Related]
15. Can serum prostate-specific antigen replace bone scintigraphy in the follow-up of metastatic prostatic cancer?
Sissons GR; Clements R; Peeling WB; Penney MD
Br J Radiol; 1992 Oct; 65(778):861-4. PubMed ID: 1384917
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Nakamoto Y; Osman M; Wahl RL
Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
[TBL] [Abstract][Full Text] [Related]
17. Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?
Staudenherz A; Steiner B; Puig S; Kainberger F; Leitha T
Cancer; 1999 Jan; 85(1):153-5. PubMed ID: 9921987
[TBL] [Abstract][Full Text] [Related]
18. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
19. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H
J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356
[TBL] [Abstract][Full Text] [Related]
20. Musculoskeletal pain as an indicator of occult malignancy. Yield of bone scintigraphy.
Jacobson AF
Arch Intern Med; 1997 Jan; 157(1):105-9. PubMed ID: 8996047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
